Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP435357.RALU7qNT0YGPCArT_YMT7JoKSZlIm5ijN0kFfBfid80O8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP435357.RALU7qNT0YGPCArT_YMT7JoKSZlIm5ijN0kFfBfid80O8130_assertion type Assertion NP435357.RALU7qNT0YGPCArT_YMT7JoKSZlIm5ijN0kFfBfid80O8130_head.
- NP435357.RALU7qNT0YGPCArT_YMT7JoKSZlIm5ijN0kFfBfid80O8130_assertion description "[The objective of this study was to investigate whether tumor derived fibronectin alternatively spliced EDA domain has a lymphangiogenic potency on human lymphatic endothelial cells (LECs) in tumor generation to facilitate tumor lymphatic metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435357.RALU7qNT0YGPCArT_YMT7JoKSZlIm5ijN0kFfBfid80O8130_provenance.
- NP435357.RALU7qNT0YGPCArT_YMT7JoKSZlIm5ijN0kFfBfid80O8130_assertion evidence source_evidence_literature NP435357.RALU7qNT0YGPCArT_YMT7JoKSZlIm5ijN0kFfBfid80O8130_provenance.
- NP435357.RALU7qNT0YGPCArT_YMT7JoKSZlIm5ijN0kFfBfid80O8130_assertion SIO_000772 20023414 NP435357.RALU7qNT0YGPCArT_YMT7JoKSZlIm5ijN0kFfBfid80O8130_provenance.
- NP435357.RALU7qNT0YGPCArT_YMT7JoKSZlIm5ijN0kFfBfid80O8130_assertion wasDerivedFrom befree-20140225 NP435357.RALU7qNT0YGPCArT_YMT7JoKSZlIm5ijN0kFfBfid80O8130_provenance.
- NP435357.RALU7qNT0YGPCArT_YMT7JoKSZlIm5ijN0kFfBfid80O8130_assertion wasGeneratedBy ECO_0000203 NP435357.RALU7qNT0YGPCArT_YMT7JoKSZlIm5ijN0kFfBfid80O8130_provenance.